ARNA Crosses Above Average Analyst Target
July 03, 2019 at 08:13 AM EDT
In recent trading, shares of Arena Pharmaceuticals Inc (ARNA) have crossed above the average analyst 12-month target price of $60.00, changing hands for $60.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..